ICAD, INC. - Common Stock, par value $0.01 (ICAD)

90 filings reported holding ICAD - ICAD, INC. - Common Stock, par value $0.01 as of Q4 2020.
ICAD, INC. - Common Stock, par value $0.01 (ICAD) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 10,180,671 shares of 27,407,170 outstanding shares and own 37.15% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,452,196 shares), Portolan Capital Management, LLC (1,161,199 shares), G2 Investment Partners Management LLC (885,369 shares), FEDERATED HERMES, INC. (649,553 shares), Parkman Healthcare Partners LLC (542,602 shares), WELLINGTON MANAGEMENT GROUP LLP (456,695 shares), Fairpointe Capital LLC (348,276 shares), STATE STREET CORP (336,131 shares), GEODE CAPITAL MANAGEMENT, LLC (311,118 shares), and RENAISSANCE TECHNOLOGIES LLC (260,590 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.